Journal Article Summary
The article investigates the effectiveness and patient preference between two medications, sildenafil citrate and tadalafil, for treating erectile dysfunction (ED) in Chinese men who have never used phosphodiesterase 5 (PDE5) inhibitors before. This topic is significant because ED affects many men globally and can impact their quality of life and relationships. Understanding which medication patients prefer can help healthcare providers make better treatment recommendations tailored to individual needs.
In this multicenter, randomized, open-label crossover study, 383 eligible men aged 18 to 65 with a history of ED were enrolled. After a baseline assessment, participants were randomly assigned to receive either tadalafil (20 mg) or sildenafil (100 mg) for eight weeks, followed by a switch to the other medication for another eight weeks. At the end of the study, 69.1% of the men preferred tadalafil, citing its longer duration of action as a key reason for their choice. Both medications were found to be effective and safe, with headache being the most common side effect reported.
The study has some limitations, including its open-label design, which may have influenced patient perceptions and preferences due to potential biases. Additionally, the study only included men who had never used PDE5 inhibitors, which may limit the generalizability of the findings. Patients should discuss their treatment options with healthcare professionals, considering individual health conditions and preferences, to determine the most suitable approach for managing ED.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Bai Wen-Jun, Li Hong-Jun, Dai Yu-Tian, He Xue-You, Huang Yi-Ran, Liu Ji-Hong, Sorsaburu Sebastian, Ji Chen, et al.. An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naïve to phosphodiesterase 5 inhibitor therapy. Asian Journal of Andrology 2015. DOI: 10.4103/1008-682X.143244. PMID: 25370206. PMCID: PMC4291880.
Featured Pill Pals Product
Tadalafil 5 MG Tablets --- Generic for Cialis --- Ajanta Pharma
Tadalafil 5 MG Tablets --- Generic for Cialis --- Ajanta Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
